DALLAS, TX / ACCESSWIRE / November 19, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the appointment of Dr. Hiroshi Ohrui to its Scientific Advisory Board. Dr. Ohrui is a distinguished ...

Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in developmentCLMBRs are being installed in three of Armah Sports Group's ...

As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at ...

PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates Foundation ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

PALO ALTO, CA / ACCESSWIRE / November 19, 2024 / Bioz, Inc., a driving force in AI-enhanced citation tracking, is pleased to announce a new partnership with DNA Polymerase Technology. By integrating ...

Commercial HighlightsAppointment of Jantzen Cole as Vice President of Market Development, Extremities, to drive the Company's acceleration beyond the spine marketStrategic expansion opens new ...

ExpansionSiegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CESTMedia ReleaseZofingen, November 19, 2024Siegfried (SIX: SFZN), a leading global Contract ...

Month figures/ConferenceFormycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences 19.11.2024 / 06:30 CET/CESTThe issuer is ...

Australia’s Human Research Ethics Committees (HREC) cleared first-in-human study of drug candidate PLL001 PLL001 aims at restoring microbiome and stopping gut from leaking to treat root cause of ALS, ...